XVIPY OTC
Xvivo Perfusion AB (publ)
1W: -13.2%
1M: -29.1%
YTD: -15.9%
$5.50
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$111M
+140.4% ▲
5Y CAGR: +30.4%
Capital Expenditures
$71M
+50.9% ▲
5Y CAGR: -3.3%
Free Cash Flow
$41M
+141.5% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$131M
-143.6% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$57M | $7M | $22M | $92M | $172M |
| Depreciation & Amort. | $30M | $32M | $42M | $31M | $67M |
| Stock-Based Comp. | $18M | $3M | $0 | $2M | $7M |
| Change in Working Capital | -$4M | -$23M | -$22M | -$39M | -$79M |
| Other Non-Cash Items | $19M | -$28M | -$14M | -$39M | -$56M |
| Operating Cash Flow | -$12M | -$12M | $28M | $46M | $111M |
| — Investing Activities — | |||||
| Capital Expenditures | -$65M | -$94M | -$131M | -$43M | -$71M |
| Acquisitions (Net) | -$201M | -$93M | -$67M | -$18M | -$50M |
| Investment Purchases | -$536K | -$401K | $179M | $0 | $0 |
| Investment Sales | $62M | $84M | $769K | $0 | $0 |
| Other Investing | -$62M | -$84M | -$179M | -$101M | -$123M |
| Investing Cash Flow | -$267M | -$188M | -$198M | -$162M | -$244M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | -$6M | $0 | $0 | -$11M |
| Stock Repurchased | $0 | $0 | -$368K | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$6M | -$5M | -$7M | -$11M | $0 |
| Financing Cash Flow | $483M | $235M | -$7M | $419M | -$11M |
| Net Change in Cash | $194M | $44M | -$152M | $300M | -$131M |
| Cash End of Period | $354M | $399M | $247M | $546M | $416M |
| Free Cash Flow | -$77M | -$106M | -$103M | -$98M | $41M |